Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Y. H. Lee, S. C. Bae
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.